UBS Group’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.13M Sell
8,780
-2,820
-24% -$907K ﹤0.01% 4584
2026
Q2
$5.6M Sell
11,600
-69,560
-86% -$18.5M ﹤0.01% 4054
2026
Q1
$8.9M Buy
81,160
+21,660
+36% +$3.09M ﹤0.01% 3488
2025
Q4
$9.9M Sell
59,500
-3,979
-6% -$666K ﹤0.01% 3295
2025
Q3
$12.4M Buy
+63,479
New +$10.4M ﹤0.01% 3061
2024
Q4
– Sell
-10,000
Closed -$524K – 10513
2024
Q3
$524K Hold
10,000
– – ﹤0.01% 5191
2024
Q2
$605K Buy
+10,000
New +$694K ﹤0.01% 4853

Other funds holding ALAB

UBS Group's ALAB Position: Q3 2026 in Review

UBS Group reduced its Astera Labs (ALAB) stake by 20% in Q3 2026, selling an estimated $50.6M and leaving 644,794 shares worth $230M. The position accounts for 0.03% of the portfolio, ranked #586.

UBS Group first reported a position in ALAB in Q1 2024 and has held it in 11 quarters since. The position peaked at $387M in Q2 2026. 1,006 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • UBS Group held 644,794 shares of Astera Labs worth $230M as of Q3 2026.
  • UBS Group sold 157,230 Astera Labs shares in Q3 2026, an estimated $50.6M.
  • Astera Labs made up 0.03% of UBS Group's portfolio in Q3 2026, its #586 holding.
  • UBS Group first reported a position in Astera Labs in Q1 2024 and has held it in 11 quarters since.
  • UBS Group's Astera Labs position peaked at $387M in Q2 2026.
  • 1,006 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.